Advanced Breast Cancer - OECI
Advanced Breast Cancer - OECI Advanced Breast Cancer - OECI
Advanced Breast Cancer Second International Consensus Conference Coordinators: Fatima Cardoso Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, PT David A. Cameron Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK Alberto Costa Scientific Director, European School of Oncology, Milan, IT and Bellinzona, CH Tanja Cufer University Clinic of Respiratory & Allergic Diseases Golnik, Golnik, SL Lesley Fallowfield Sussex Health Outcomes Research & Education in Cancer, Brighton & Sussex Medical School, University of Sussex, Brighton, UK Prudence A. Francis Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, AU ESO Advanced Breast Cancer Task Force Eric P. Winer Breast Oncology Center, Dana-Farber Cancer Institute, Boston, US Joseph Gligorov Department of Medical Oncology, CancerEst APHP Tenon, University Paris VI, Paris, FR Stella Kyriakides Europa Donna Cyprus, Nicosia, CY Nancy U. Lin Breast Oncology Center, Dana-Farber Cancer Institute, Boston, US Olivia Pagani Department of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, CH Elzbieta Senkus-Konefka Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, PL Christoph Thomssen Clinic for Gynaecology, Martin-Luther-Universität, Klinikum Kröllwitz, Halle (Saale), DE 8 ABC2 7-9 NOVEMBER 2013, LISBON, PORTUGAL
Coordinators: Fatima Cardoso Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, PT ABC2 Patient Advocacy Committee Kathy Redmond Cancer World Magazine, Editor, Lugano, CH Dian “CJ” M. Corneliussen-James METAvivor Research and Support, Annapolis, US Susan Knox Europa Donna, Milan, IT Amelia Pinto Leite Europa Donna, Portugal, Lisbon, PT Musa Mayer AdvancedBC.org, New York, US, Shirley Mertz Metastatic Breast Cancer Network US, Inverness, US Maxine Morand Australian Breast Cancer Network Victoria, Camberwell, AU Kimberly A. Sabelko Komen Foundation, Dallas, US Breast cancer patient advocacy programme Representatives of breast cancer patient advocacy groups are warmly invited to participate in ABC2 and actively contribute to the scientific programme and consensus sessions. Furthermore, in collaboration with several leading breast cancer patient advocacy groups worldwide, specific additional Meet the Expert sessions have been scheduled. 7-9 NOVEMBER 2013, LISBON, PORTUGAL ABC2 9
- Page 1 and 2: September-October 2012 Number 50 IT
- Page 3 and 4: Dates and Team By 8 July 2013 Abstr
- Page 5 and 6: General information Venue ABC2 will
- Page 7: Kimberley L. Blackwell Breast Cance
- Page 11 and 12: Preliminary programme outline Wedne
- Page 13 and 14: 10:45 Inoperable locally advanced b
- Page 15 and 16: Abstract submission Deadline for su
- Page 17 and 18: Group registration The online group
- Page 19 and 20: Hotel accommodation Deadline for bo
- Page 21 and 22: Optional tours Viagens Abreu offers
- Page 23 and 24: Half day tour to Óbidos and Fátim
- Page 25 and 26: Notes .............................
- Page 27 and 28: It’s easy to save money on your f
<strong>Advanced</strong> <strong>Breast</strong> <strong>Cancer</strong> Second International Consensus Conference<br />
Coordinators:<br />
Fatima Cardoso<br />
<strong>Breast</strong> <strong>Cancer</strong> Unit,<br />
Champalimaud <strong>Cancer</strong> Center,<br />
Lisbon, PT<br />
David A. Cameron<br />
Edinburgh <strong>Breast</strong> Unit, Western General Hospital,<br />
Edinburgh, UK<br />
Alberto Costa<br />
Scientific Director, European School of Oncology,<br />
Milan, IT and Bellinzona, CH<br />
Tanja Cufer<br />
University Clinic of Respiratory & Allergic Diseases<br />
Golnik, Golnik, SL<br />
Lesley Fallowfield<br />
Sussex Health Outcomes Research & Education<br />
in <strong>Cancer</strong>, Brighton & Sussex Medical School,<br />
University of Sussex, Brighton, UK<br />
Prudence A. Francis<br />
Division of <strong>Cancer</strong> Medicine, Peter MacCallum<br />
<strong>Cancer</strong> Centre, Melbourne, AU<br />
ESO <strong>Advanced</strong> <strong>Breast</strong><br />
<strong>Cancer</strong> Task Force<br />
Eric P. Winer<br />
<strong>Breast</strong> Oncology Center,<br />
Dana-Farber <strong>Cancer</strong><br />
Institute, Boston, US<br />
Joseph Gligorov<br />
Department of Medical Oncology, <strong>Cancer</strong>Est APHP<br />
Tenon, University Paris VI, Paris, FR<br />
Stella Kyriakides<br />
Europa Donna Cyprus, Nicosia, CY<br />
Nancy U. Lin<br />
<strong>Breast</strong> Oncology Center, Dana-Farber <strong>Cancer</strong><br />
Institute, Boston, US<br />
Olivia Pagani<br />
Department of Medical Oncology, Oncology<br />
Institute of Southern Switzerland, Bellinzona, CH<br />
Elzbieta Senkus-Konefka<br />
Department of Oncology and Radiotherapy, Medical<br />
University of Gdansk, Gdansk, PL<br />
Christoph Thomssen<br />
Clinic for Gynaecology, Martin-Luther-Universität,<br />
Klinikum Kröllwitz, Halle (Saale), DE<br />
8<br />
ABC2 7-9 NOVEMBER 2013, LISBON, PORTUGAL
Change language